The transforming growth factor-beta superfamily of receptors.

The transforming growth factor- (TGF-) superfamily of receptors comprises two groups of transmembrane serine-threonine kinase receptors, so called type I, and type II receptors, that are activated following engagement by members of the TGF- superfamily of ligands. These events specify diverse downstream responses that are differentially regulated by controlling access and activation of the ligands, their receptors and downstream substrates in different cell types. The purpose of this review is to describe the biochemical properties of these receptors, focusing specifically on the mechanisms regulating receptor/ligand interactions and activation in mammalian cells. © 2003 Elsevier Ltd. All rights reserved.

[1]  P. Hoodless,et al.  Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.

[2]  R. Derynck,et al.  Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. , 1993, Science.

[3]  M. Matzuk,et al.  Studying TGF-β superfamily signaling by knockouts and knockins , 2001, Molecular and Cellular Endocrinology.

[4]  D. Constam,et al.  Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases , 1999, The Journal of cell biology.

[5]  P. Howe,et al.  TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.

[6]  W. Vale,et al.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Sporn,et al.  Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. , 1996, Biochemistry.

[8]  H. Schnaper,et al.  Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Celeste,et al.  Requirement of BMP-2-induced Phosphatidylinositol 3-Kinase and Akt Serine/Threonine Kinase in Osteoblast Differentiation and Smad-dependent BMP-2 Gene Transcription* , 2002, The Journal of Biological Chemistry.

[10]  K. Miyazono,et al.  Divergence and convergence of TGF‐β/BMP signaling , 2001, Journal of cellular physiology.

[11]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[12]  A. Roberts,et al.  Zebrafish nma is involved in TGFβ family signaling , 2000, Genesis.

[13]  Xiang-Xi Xu,et al.  The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway , 2001, The EMBO journal.

[14]  C. Heldin,et al.  Characterization of a 60‐kDa cell surface‐associated transforming growth factor‐β binding protein that can interfere with transforming growth factor‐β receptor binding , 1997, Journal of cellular physiology.

[15]  J. Massagué,et al.  Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.

[16]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[17]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[18]  S. Hubchak,et al.  Cytoskeletal rearrangement and signal transduction in TGF-beta1-stimulated mesangial cell collagen accumulation. , 2003, Journal of the American Society of Nephrology : JASN.

[19]  H. Oppermann,et al.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.

[20]  Hiroyuki Aburatani,et al.  Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells , 2002, Journal of cellular physiology.

[21]  R. Frey,et al.  TGFβ regulation of mitogen-activated protein kinases in human breast cancer cells , 1997 .

[22]  Ruth Lehr,et al.  Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). , 2002, Journal of medicinal chemistry.

[23]  N. Hooper,et al.  Characterization of a 150 kDa accessory receptor for TGF‐β1 on keratinocytes: Direct evidence for a GPI anchor and ligand binding of the released form , 2001, Journal of cellular biochemistry.

[24]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[25]  S. Willis,et al.  Formation and activation by phosphorylation of activin receptor complexes. , 1996, Molecular endocrinology.

[26]  Ying E. Zhang,et al.  TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses , 2002 .

[27]  D. Davies,et al.  Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. , 1992, Science.

[28]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[29]  E. Stanley,et al.  Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 , 2003, The Journal of cell biology.

[30]  M. Letarte,et al.  Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation , 1998, Cell and Tissue Research.

[31]  W. Kwiatkowski,et al.  The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.

[32]  K. Miyazono,et al.  Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.

[33]  A. Balmain,et al.  TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest , 2000 .

[34]  Michael D. Schneider,et al.  Transforming Growth Factor-β Receptor-associated Protein 1 Is a Smad4 Chaperone* , 2001, The Journal of Biological Chemistry.

[35]  W. Vale,et al.  Phosphorylation regulation of the interaction between Smad7 and activin type I receptor , 2002, FEBS letters.

[36]  F. Otsuka,et al.  Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells* , 2003, The Journal of Biological Chemistry.

[37]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[38]  M. Reiss,et al.  TLP, a novel modulator of TGF‐β signaling, has opposite effects on Smad2‐ and Smad3‐dependent signaling , 2003, The EMBO journal.

[39]  D. Rifkin,et al.  Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.

[40]  G. Risbridger,et al.  Activins and inhibins in endocrine and other tumors. , 2001, Endocrine reviews.

[41]  J. Smith,et al.  Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects , 1995, The Journal of cell biology.

[42]  T. Kirsch,et al.  Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.

[43]  K. Miyazono,et al.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Heldin,et al.  Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses* , 2003, The Journal of Biological Chemistry.

[45]  W. Vale,et al.  Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling* , 2003, The Journal of Biological Chemistry.

[46]  A. Eszterhas,et al.  TGF-β1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[47]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[48]  K. Miyazono,et al.  Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. , 1999, Journal of cell science.

[49]  Harvey F. Lodish,et al.  Functional Roles for the Cytoplasmic Domain of the Type III Transforming Growth Factor β Receptor in Regulating Transforming Growth Factor β Signaling* , 2001, The Journal of Biological Chemistry.

[50]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[51]  Y G Chen,et al.  Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. , 2000, The Journal of biological chemistry.

[52]  T. Tan,et al.  Hematopoietic Progenitor Kinase 1 Is a Component of Transforming Growth Factor β-induced c-Jun N-terminal Kinase Signaling Cascade* , 1999, The Journal of Biological Chemistry.

[53]  K. Miyazono,et al.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[54]  F. Luyten,et al.  Cartilage‐Derived Morphogenetic Proteins and Osteogenic Protein‐1 Differentially Regulate Osteogenesis , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  J. Massagué,et al.  Structural basis of Smad2 recognition by the Smad anchor for receptor activation. , 2000, Science.

[56]  S Kumar,et al.  Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers. , 1999, Genetics.

[57]  S. Wong,et al.  Endoglin expression on human microvascular endothelial cells , 2000 .

[58]  K. Lewis,et al.  Betaglycan binds inhibin and can mediate functional antagonism of activin signalling , 2000, Nature.

[59]  Ester Piek,et al.  Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .

[60]  H. Moses,et al.  Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[61]  J. Massagué,et al.  Activation of signalling by the activin receptor complex , 1996, Molecular and cellular biology.

[62]  Toshihiko Ogura,et al.  Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[63]  W. Vale,et al.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation , 1997, Molecular and cellular biology.

[64]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[65]  K. Miyazono,et al.  Smurf1 Regulates the Inhibitory Activity of Smad7 by Targeting Smad7 to the Plasma Membrane* 210 , 2002, The Journal of Biological Chemistry.

[66]  V. Rosen,et al.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.

[67]  C. Deng,et al.  Disruption of Transforming Growth Factor-β Signaling in ELF β-Spectrin-Deficient Mice , 2003, Science.

[68]  E. Canalis,et al.  Skeletal growth factors. , 2000, Critical reviews in eukaryotic gene expression.

[69]  S. P. Oh,et al.  Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. , 2002, Genes & development.

[70]  A. Brivanlou,et al.  The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. , 2001, Genes & development.

[71]  Liliana Attisano,et al.  SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.

[72]  J. Massagué,et al.  Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors* , 1999, The Journal of Biological Chemistry.

[73]  R. Davis,et al.  Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.

[74]  E. Robertis,et al.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β , 2002, Nature Cell Biology.

[75]  K. Miyazono,et al.  Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5* , 1996, The Journal of Biological Chemistry.

[76]  J. L. Rosa,et al.  Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP‐2 , 2002, FEBS letters.

[77]  P. Donahoe,et al.  The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors , 1996, Cell.

[78]  E. Nishida,et al.  Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.

[79]  J. Wrana,et al.  Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.

[80]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[81]  M. Centrella,et al.  Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor β2 (*) , 1995, The Journal of Biological Chemistry.

[82]  D. Constam,et al.  Extraembryonic proteases regulate Nodal signalling during gastrulation , 2002, Nature Cell Biology.

[83]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[84]  M. D. de Caestecker,et al.  Transcriptional Cross-talk between Smad, ERK1/2, and p38 Mitogen-activated Protein Kinase Pathways Regulates Transforming Growth Factor-β-induced Aggrecan Gene Expression in Chondrogenic ATDC5 Cells* , 2001, The Journal of Biological Chemistry.

[85]  S. Schmid,et al.  Regulation of signal transduction by endocytosis. , 2000, Current opinion in cell biology.

[86]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[87]  J. Visser,et al.  The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. , 2001, Molecular endocrinology.

[88]  Jeffrey L. Wrana,et al.  Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA , 2000, Molecular and Cellular Biology.

[89]  M. Caestecker,et al.  Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension , 2001, Respiratory research.

[90]  Guang-Quan Zhao,et al.  Consequences of knocking out BMP signaling in the mouse , 2003, Genesis.

[91]  S. S. Huang,et al.  Transforming growth factor beta (TGF-beta) type V receptor has a TGF-beta-stimulated serine/threonine-specific autophosphorylation activity. , 1992, The Journal of biological chemistry.

[92]  A. Schier,et al.  EGF-CFC proteins are essential coreceptors for the TGF-β signals Vg1 and GDF1 , 2003 .

[93]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[94]  W. Van Hul,et al.  Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. , 2002, Developmental biology.

[95]  M. Grütter,et al.  The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.

[96]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[97]  J. Massagué,et al.  Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system , 1991, Cell.

[98]  S. Cook,et al.  Altered Transforming Growth Factor β Signaling in Epithelial Cells when Ras Activation Is Blocked* , 1996, The Journal of Biological Chemistry.

[99]  J Kuriyan,et al.  The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. , 2001, Molecular cell.

[100]  Shashank Deep,et al.  Crystal structure of the human TβR2 ectodomain–TGF-β3 complex , 2002, Nature Structural Biology.

[101]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.

[102]  M. Brown,et al.  Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells. , 1999, Experimental cell research.

[103]  J. Doré,et al.  Internalization-Dependent and -Independent Requirements for Transforming Growth Factor β Receptor Signaling via the Smad Pathway , 2002, Molecular and Cellular Biology.

[104]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[105]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[106]  D. L. Griffith,et al.  Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[107]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[108]  L. Attisano,et al.  Role of Endoglin in Cellular Responses to Transforming Growth Factor-β , 1998, The Journal of Biological Chemistry.

[109]  H. Lodish,et al.  Transforming Growth Factor-β Induces Formation of a Dithiothreitol-resistant Type I/Type II Receptor Complex in Live Cells* , 1999, The Journal of Biological Chemistry.

[110]  C. Niehrs,et al.  Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.

[111]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[112]  R. Assoian,et al.  Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression. , 2003, Developmental cell.

[113]  G. Thomsen,et al.  Ventral mesoderm induction and patterning by bone morphogenetic protein heterodimers in Xenopus embryos , 1998, Mechanisms of Development.

[114]  S. Lye,et al.  Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. , 1994, Biology of reproduction.

[115]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[116]  D. Bernard,et al.  Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors , 2002, Molecular and Cellular Endocrinology.

[117]  L. Johnson,et al.  Active and Inactive Protein Kinases: Structural Basis for Regulation , 1996, Cell.

[118]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[119]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[120]  A. Roberts,et al.  Sorting Nexin 6, a Novel SNX, Interacts with the Transforming Growth Factor-β Family of Receptor Serine-Threonine Kinases* , 2001, The Journal of Biological Chemistry.

[121]  K. M. Mulder,et al.  Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.

[122]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[123]  C. Heldin,et al.  Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. , 2002, Molecular biology of the cell.

[124]  J. Massagué,et al.  Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.

[125]  C. Heldin,et al.  Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase. , 2002, Biochemistry.

[126]  Yusuke Nakamura,et al.  Axin Facilitates Smad3 Activation in the Transforming Growth Factor β Signaling Pathway , 2001, Molecular and Cellular Biology.

[127]  Jeffrey L. Wrana,et al.  Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.

[128]  Jian-Dong Li,et al.  Transforming Growth Factor- (cid:1) -Smad Signaling Pathway Negatively Regulates Nontypeable Haemophilus influenzae -induced MUC5AC Mucin Transcription via Mitogen-activated Protein Kinase (MAPK) Phosphatase-1-dependent Inhibition of p38 MAPK* , 2022 .

[129]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[130]  S. Rutella,et al.  CD105 (Endoglin) Expression on Hematopoietic Stem/Progenitor Cells , 2001, Leukemia & lymphoma.

[131]  A. V. van Kessel,et al.  Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts , 1996, International journal of cancer.

[132]  J. Wrana,et al.  Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[133]  H. Lodish,et al.  A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. , 2001, The Journal of biological chemistry.

[134]  Junwei Yang,et al.  Transforming Growth Factor-β1 Potentiates Renal Tubular Epithelial Cell Death by a Mechanism Independent of Smad Signaling* , 2003, The Journal of Biological Chemistry.

[135]  C. Heldin,et al.  Functional antagonism between activin and osteogenic protein‐1 in human embryonal carcinoma cells , 1999, Journal of cellular physiology.

[136]  J. Massagué,et al.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.

[137]  S. J. Lee,et al.  GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. , 1993, The Journal of biological chemistry.

[138]  Stephanie Birkey Reffey,et al.  X-linked Inhibitor of Apoptosis Protein Functions as a Cofactor in Transforming Growth Factor-β Signaling* , 2001, The Journal of Biological Chemistry.

[139]  P. S. Klein,et al.  SANE, a Novel LEM Domain Protein, Regulates Bone Morphogenetic Protein Signaling through Interaction with Smad1* , 2003, The Journal of Biological Chemistry.

[140]  Naoto Ueno,et al.  XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1–TAK1 in the BMP signaling pathway , 1999, The EMBO journal.

[141]  A. Schier,et al.  The EGF-CFC gene family in vertebrate development. , 2000, Trends in genetics : TIG.

[142]  S. Pangas,et al.  Activin Signal Transduction Pathways , 2000, Trends in Endocrinology & Metabolism.

[143]  H. Schnaper,et al.  Smad3 and PKCδ mediate TGF-β1-induced collagen I expression in human mesangial cells , 2003 .

[144]  K. Miyazono,et al.  Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. , 1993, Oncogene.

[145]  W. Sebald,et al.  Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. , 1999, Journal of molecular biology.

[146]  M. C. Hu,et al.  Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction* , 1997, The Journal of Biological Chemistry.

[147]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[148]  J. Lemonnier,et al.  Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[149]  P. Caroni,et al.  Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase , 1998, Nature.

[150]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[151]  L. Attisano,et al.  Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1* , 1999, The Journal of Biological Chemistry.

[152]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[153]  M. Whitman,et al.  Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. , 2001, Molecular cell.

[154]  S. Bae,et al.  Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein , 2002, Oncogene.

[155]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[156]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[157]  Morgan Huse,et al.  Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12 , 1999, Cell.

[158]  C. J. Gimeno,et al.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[159]  M. Mercola,et al.  TGF-β Superfamily Signaling and Left-Right Asymmetry , 2001, Science's STKE.

[160]  Robert A. Weinberg,et al.  TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation , 2001, Nature Cell Biology.